NCIC CTG MAP.3: Symptoms and quality of life (QoL) among racial/ethnic minority women taking the aromatase inhibitor (AI) exemestane (EXE) for breast cancer risk reduction.
Beverly Moy
No relevant relationships to disclose
Dongsheng Tu
No relevant relationships to disclose
Harriet Richardson
No relevant relationships to disclose
Elizabeth Maunsell
No relevant relationships to disclose
Paul E. Goss
Honoraria - Pfizer